411 related articles for article (PubMed ID: 30958606)
1. Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination.
Sun X; Zeng L; Huang Y
J Gene Med; 2019 Jul; 21(7):e3089. PubMed ID: 30958606
[TBL] [Abstract][Full Text] [Related]
2. The ReNAissanCe of mRNA-based cancer therapy.
Van Lint S; Renmans D; Broos K; Dewitte H; Lentacker I; Heirman C; Breckpot K; Thielemans K
Expert Rev Vaccines; 2015 Feb; 14(2):235-51. PubMed ID: 25263094
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells.
Le Moignic A; Malard V; Benvegnu T; Lemiègre L; Berchel M; Jaffrès PA; Baillou C; Delost M; Macedo R; Rochefort J; Lescaille G; Pichon C; Lemoine FM; Midoux P; Mateo V
J Control Release; 2018 May; 278():110-121. PubMed ID: 29630987
[TBL] [Abstract][Full Text] [Related]
4. mRNA therapeutics in cancer immunotherapy.
Beck JD; Reidenbach D; Salomon N; Sahin U; Türeci Ö; Vormehr M; Kranz LM
Mol Cancer; 2021 Apr; 20(1):69. PubMed ID: 33858437
[TBL] [Abstract][Full Text] [Related]
5. Challenges and advances towards the rational design of mRNA vaccines.
Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
[TBL] [Abstract][Full Text] [Related]
6. Lipid-based mRNA vaccine delivery systems.
Midoux P; Pichon C
Expert Rev Vaccines; 2015 Feb; 14(2):221-34. PubMed ID: 25540984
[TBL] [Abstract][Full Text] [Related]
7. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
H Yi D; Appel S
Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
9. Enhancing tumor specific immune responses by transcutaneous vaccination.
Saliba H; Heurtault B; Bouharoun-Tayoun H; Flacher V; Frisch B; Fournel S; Chamat S
Expert Rev Vaccines; 2017 Nov; 16(11):1079-1094. PubMed ID: 28937293
[TBL] [Abstract][Full Text] [Related]
10. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
Shurin MR; Gregory M; Morris JC; Malyguine AM
Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
[TBL] [Abstract][Full Text] [Related]
12. RNA transfected dendritic cells as cancer vaccines.
Mitchell DA; Nair SK
Curr Opin Mol Ther; 2000 Apr; 2(2):176-81. PubMed ID: 11249639
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant-Enhanced mRNA Vaccines.
Bialkowski L; Van der Jeught K; Renmans D; van Weijnen A; Heirman C; Keyaerts M; Breckpot K; Thielemans K
Methods Mol Biol; 2017; 1499():179-191. PubMed ID: 27987150
[TBL] [Abstract][Full Text] [Related]
14. mRNA-based dendritic cell vaccines.
Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
[TBL] [Abstract][Full Text] [Related]
15. RNA-Based Vaccines in Cancer Immunotherapy.
McNamara MA; Nair SK; Holl EK
J Immunol Res; 2015; 2015():794528. PubMed ID: 26665011
[TBL] [Abstract][Full Text] [Related]
16. The potential of DNA vaccination against tumor-associated antigens for antitumor therapy.
Haupt K; Roggendorf M; Mann K
Exp Biol Med (Maywood); 2002 Apr; 227(4):227-37. PubMed ID: 11910045
[TBL] [Abstract][Full Text] [Related]
17. Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy.
Berlyn KA; Ponniah S; Stass SA; Malone JG; Hamlin-Green G; Lim JK; Cottler-Fox M; Tricot G; Alexander RB; Mann DL; Malone RW
J Biotechnol; 1999 Aug; 73(2-3):155-79. PubMed ID: 10486925
[TBL] [Abstract][Full Text] [Related]
18. The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy.
Dewitte H; Van Lint S; Heirman C; Thielemans K; De Smedt SC; Breckpot K; Lentacker I
J Control Release; 2014 Nov; 194():28-36. PubMed ID: 25151979
[TBL] [Abstract][Full Text] [Related]
19. mRNA Cancer Vaccines.
Fiedler K; Lazzaro S; Lutz J; Rauch S; Heidenreich R
Recent Results Cancer Res; 2016; 209():61-85. PubMed ID: 28101688
[TBL] [Abstract][Full Text] [Related]
20. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination.
Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K
Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
